论文部分内容阅读
目的:分析吸入沙美特罗替卡松治疗慢性阻塞性肺病的临床疗效。方法:选择2010年09月到2012年10月我院收治的50例慢性阻塞性肺部疾病患者,将其作为观察组,采用沙美特罗—替卡松进行治疗。选取50例一般资料不存在显著差异的慢性阻塞性肺部疾病患者,将其作为对照组,采用基础治疗方式,对比两组的临床症状变化情况。结果:经治疗,观察组的临床症状得到有效缓解。结论:对于慢性阻塞性肺部疾病患者,在基础治疗的前提下,采用沙美特罗——替卡松进行治疗,具有良好的效果,能够缓解患者的临床症状,改善其肺部功能。
Objective: To analyze the clinical effects of inhaled salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease. Methods: Fifty patients with chronic obstructive pulmonary disease admitted to our hospital from September 2010 to October 2012 were selected as the observation group and treated with salmeterol-ticasone. Fifty patients with chronic obstructive pulmonary disease who did not show significant difference in the general data were selected as the control group and the basic treatment methods were used to compare the clinical symptoms of the two groups. Results: After treatment, the clinical symptoms of the observation group were effectively relieved. CONCLUSIONS: In patients with chronic obstructive pulmonary disease, salmeterol-ticarcadine is used as a treatment for patients with chronic obstructive pulmonary disease and is effective in relieving clinical symptoms and improving lung function in patients with chronic obstructive pulmonary disease.